THERAPY DOSSIER · th-a1dccef363d1

Brahma Rasayana; Chyavanaprash

Nutraceutical

Evidence & regulatory context

Mechanism: Not recorded
Target: Not recorded
Injury models: Chemical/toxin
Reported indication: Not recorded
First approval: Not recorded
Development stage: Not recorded
ChEMBL record: Not recorded
ChEMBL max phase: Not recorded
Synonyms: Not recorded
Note: Not recorded

Clinical trials 0

0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.

No linked human trial in this dataset.

Preclinical evidence 1

1 studies reported at therapy level; 1 evidence entries itemised.

PMID 27461610 ↗2016Reported benefit

Protective effect of ayurvedic formulations against doxorubicin-induced cardiotoxicity: Preliminary studies on Brahma Rasayana and Chyavanaprash

MouseChemical/toxinSwiss albinoMale1 and 2 g/kg

Model: Doxorubicin-induced acute cardiotoxicity

Both formulations maintained antioxidant status and prevented doxorubicin-induced cardiac tissue damage, marker enzyme release and alteration of cardiac architecture

Extraction: extract · Supplied extraction confidence: 0.7. Machine-extracted fields require source verification.

Loading the evidence…